News

CHEMO have recently completed the acquisition of 70% of ALTIAN PHARMA, one of the leading pharmaceutical companies in Central America and headquartered in Guatemala. This acquisition is in line with the company's internationalization strategy and will strengthen its position in this region.

Ever since the company started international expansion in 2003, Chemo’s goal has always been to establish its own presence in markets with high development potential such as Latin America.

With over 40 years of experience in the pharmaceutical sector, ALTIAN PHARMA leads in each and every market segment in which it participates, with over 25 leading products in the main therapeutic areas (analgesics, anti-infectives, cardiovascular, dermatology, neurology, oncology and respiratory) and over 20 in-development products to be launched soon. The company, focused on the Latin American markets and with presence in Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and the Dominican Republic, has a broad and solid commercial platform. ALTIAN PHARMA is ranked Nº 18 among 600 pharmaceutical companies in Central America.

More info:
Bárbara Scandella
Communication Responsible
Phone: + 34 91 302 15 60
Fax: +34 91 766 89 63
E-mail: comunicacion@chemogroup.com